PharmaPatents Timely Insight on Emerging Legal Developments

Tag Archives: Starmark

Federal Circuit Won’t Let Creative Compounds Muscle Its Way Into Priority Of Invention

Posted in 102; Federal Circuit Decisions

In Creative Compounds, LLC v. Starmark Laboratories, the Federal Circuit clarified that the “clear and convincing” burden of proof applies to an allegation of prior invention unless an action is brought under 35 USC § 291 or the parties identify and agree on common claimed subject matter and seek an adjudication of priority.  While Patent Reform may do away with the specific provisions at issue in this case, at least some of the principles may carry over to the proposed “derivation” proceedings.

Continue reading this entry